2026 Opioid Remediation Grant Informational

Opens: July 7th, 2026
Closes: September 1st, 2026

As part of the $26 billion national settlement, which is intended to resolve several thousand lawsuits against drug manufacturer Johnson & Johnson, which is based in New Jersey, and the country’s three major pharmaceutical distributors: AmerisourceBergen, which is headquartered in Conshohocken, Texas-based McKesson, and Cardinal Health in Ohio, Susquehanna County will receive an allocation of funds. The companies have not admitted any wrongdoing under the settlement agreement and will make payments over 18 years.

The Pennsylvania Allocation is based on input from a Working Group of Local Government Stakeholders, Counsel and Treatment Community Voices and the allocation will be established as a Trust that cannot be amended later. The total dollars allocated to Pennsylvania is $1,070,609,642 with 70% allocated to counties based on metrics i.e., overdose deaths, hospitalizations, naloxone administrations, and Morphine Milligram Equivalents (MME), 15% to Litigating Counties, Subdivisions, DAs, and Special Districts, and 15% controlled by the Legislature.

For more information, press the Grant Application button below.

Marcellus Legacy Fund Mini Grant

Opens: July 13th, 2026

Closes: September 18th, 2026

Through the Susquehanna County Marcellus Legacy Fund, the Commissioners have dedicated funding to implement a Mini-Grant Program. This program will provide grants allocations to nonprofit organizations only (municipalities and for-profit businesses are not eligible) with projects that support and advance the goals and objectives of the Marcellus Legacy Fund. The use of these funds include acquisition, development and repair of green ways, recreation trails, open space, natural areas, community conservation and beautification projects, community and heritage parks and water resource management.